Mark Schneyer is Acadia’s Chief Financial Officer, overseeing financial and selected operational functions. He has been with Acadia since 2020.
In this role, Mr. Schneyer has managed strategic finance, investor relations and communications, accounting, business development, information technology, and technical development and operations (including manufacturing and pharmaceutical development). These areas are crucial for Acadia’s pioneering efforts in commercialization and R&D, targeting unmet needs in neuroscience and rare diseases.
Prior to his current role as CFO, Mr. Schneyer was Acadia’s Senior Vice President of Business Development and Chief Business Officer. In this position, he focused on expanding Acadia’s portfolio through the execution of business development transactions to meet Acadia’s long-term growth objectives. His prior experience includes roles in business development at Pfizer and investment banking at Lazard.
Mr. Schneyer earned a Bachelor of Science in Economics with a concentration in Finance from the Wharton School of Business at the University of Pennsylvania.
